Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX5QQH
|
||||
| Drug Name |
[2-(1H-Benzoimidazol-4-yloxy)-ethyl]-[3-(5-fluoro-1H-indol-3-yl)-propyl]-amine
|
||||
| Synonyms |
CHEMBL330827
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H21FN4O
|
||||
| Canonical SMILES |
Fc1ccc2[nH]cc(CCCNCCOc3cccc4[nH]cnc34)c2c1
|
||||
| InChI |
InChI=1S/C20H21FN4O/c21-15-6-7-17-16(11-15)14(12-23-17)3-2-8-22-9-10-26-19-5-1-4-18-20(19)25-13-24-18/h1,4-7,11-13,22-23H,2-3,8-10H2,(H,24,25)
|
||||
| InChIKey |
IJEMOGZEWHHTQP-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.